Key result
Mass campaigns with oral poliovirus vaccines achieved a >99.5% worldwide reduction in polio cases between 1988 and 2004, raising questions about when and how to stop OPV vaccination.
The paper reviews the historical success of oral poliovirus vaccine in eradicating polio and raises the question of when and how to stop its use.
Answers are grounded in this paper and cite their sources.
Highlights need for coordinated OPV cessation planning; leaves open optimal timing and strategies for safe global withdrawal.
In the years before the introduction of live, attenuated oral poliovirus vaccine (OPV), there was a vigorous debate between advocates of killed and live vaccines. Proponents of live vaccine took the position that OPV would produce immunity more similar to that produced by wild viruses, providing superior individual and population protection. Proponents of inactivated poliovirus vaccine (IPV) felt that there was a risk that attenuated viruses would regain their virulence and that person-to-person spread could permit continuous circulation of vaccine virus On the basis of 50 years of experience with Salk’s killed poliovirus vaccine and >40 years of experience with Sabin’s live, attenuated OPV, who was right? As is so often the case, both sides were. The first killed vaccine significantly reduced, but did not eliminate, polio. Mass campaigns with 3 monovalent OPVs brought the number of polio cases close to 0 in the United States. Although monovalent OPVs proved impractical for routine use, high coverage with trivalent OPV eliminated the disease from the United States; the last case caused by wild virus occurred in 1978, more than a generation ago. In 2004, 1255 confirmed polio cases were reported worldwide, a >99.5% reduction from the estimated 350,000 cases that occurred in 1988. This reduction was achieved by using mass OPV campaigns, as originally envisioned by Sabin. As the global polio eradication initiative nears its ultimate goal of stopping circulation of all wild polioviruses, the questions of if and how OPV vaccination can be stopped have become increasingly important
No takes yet. Share an insight, caveat, or question.
Hull et al. (2005) conducted a review in Polio. Oral poliovirus vaccine (OPV) vs. Inactivated poliovirus vaccine (IPV) was evaluated. Mass campaigns with oral poliovirus vaccines achieved a >99.5% worldwide reduction in polio cases between 1988 and 2004, raising questions about when and how to stop OPV vaccination.
Synapse has enriched 10 related papers. Consider them for comparative context: